Mechanism
CD33; CLL1 (CLEC12A)
Assets acting on this target.
- Class
- Autologous CAR-T cell therapy targeting CD33 and CLL1
- Notes
- audit finding #1819 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT07668557
Mechanism
Assets acting on this target.
1 of 1 assets